Recent Company News

• 09:49 AM ET Feb 11, 2026
  

  Aspen Pharmacare Holdings expects H1 normalised headline EPS in range of 400.1 to 432.4 vs year-ago 645.4 (ZAR 109.67, +0.42)

• 09:13 AM ET Jan 15, 2026
  

  Transcript Intelligence: Aspen Pharmacare Holdings Aspen APAC Divestment Call (ZAR124.28, +0.94)

• 02:46 AM ET Jan 13, 2026
  

  Aspen Pharmacare Holdings to host live webcast on 15-Jan in connection with previously announced sale of Aspen APAC (ZAR 117.65, -0.79)

• 10:46 AM ET Jan 05, 2026
  

  StreetAccount M&A Summary: Week of 29-Dec

• 12:14 AM ET Dec 29, 2025
  

  Aspen Pharmacare Holdings to sell Aspen APAC to BGH Capital for A$2.37B (ZAR26.48B) (ZAR 94.50, 0.00)

• 01:12 AM ET Oct 31, 2025
  

  Aspen to receive €25M (ZAR500M) in settlement of contractual dispute announced 22-Apr (ZAR 95.12, 0.00)

• 01:57 PM ET Oct 24, 2025
  

  Aspen Pharmacare Holdings releases Integrated Report for year ended 30-Jun-25 (0800 ET) (ZAR 102.31, 0.00)

• 08:23 AM ET Oct 13, 2025
  

  StreetAccount Themes Headlines (13-Oct)

• 04:11 AM ET Oct 13, 2025
  

  Aspen Pharmacare Holdings announce South African Health Products Regulatory Authority has approved new indication for Mounjaro as chronic weight management treatment (ZAR 98.53, -0.41)

• 01:44 AM ET Oct 01, 2025
  

  Aspen Pharmacare Holdings upgraded to equal weight from underweight at Absa Bank (ZAR 94.77, 0.00)